Comparison of cefiderocol and colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review with meta-analysis and trial sequential analysis
InfectologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- BMC infectious diseases
- Publicado em
- 13 set 2024
- Citações
- 21
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Comparison of cefiderocol and colistin-based regimens for the treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: a systematic review with meta-analysis and trial sequential analysis
Yangyang Zhan, Wenchao Mao, Changyun Zhao, Difan Lu, Changqin Chen, Weihang Hu, Qi Yang
Descritores MeSH
- Cefiderocol
- Acinetobacter Infections
- Anti-Bacterial Agents
- Colistin
- Carbapenems
- Acinetobacter baumannii
- Drug Resistance, Multiple, Bacterial
- Cephalosporins
- Treatment Outcome
- Humans
Veja também
Estudos relacionados
- Eficácia comparativa dos regimes antimicrobianos para pneumonia causada por Acinetobacter baumannii resistente a fármacos: uma meta-análise de rede incluindo cefiderocol e terapias inalatórias
- Are cefiderocol or sulbactam/durlobactam better than alternative best available treatment for infection by carbapenem-resistant A. baumannii? A systematic literature review
- Efficacy and safety of antibiotics in the treatment of multidrug-resistant Acinetobacter baumannii infections: A systematic review and Bayesian network meta-analysis
- Colistin monotherapy versus colistin combination therapy in the treatment of patients with multidrug-resistant and extensively drug-resistant Acinetobacter baumannii infections: a meta-analysis